Association of serum Dkk-1 levels with β-catenin in patients with postmenopausal osteoporosis

Abstract

Wnt signaling plays an important role in the bone development and remodeling. The Wnt antagonist Dkk-1 is a potent inhibitor of bone formation. The aims of this study were firstly to compare the serum Dkk-1 levels in postmenopausal osteoporosis patients with age-matched healthy controls, and secondly, to assess the possible relationship between Dkk-1 and β-catenin, sclerostin, or bone turnover markers [CTX, PINP, N-MID-OT and 25(OH)D] in the setting of postmenopausal osteoporosis. A total of 350 patients with postmenopausal osteoporosis and 150 age-matched healthy controls were enrolled, and the serum levels of Dkk-1, β-catenin, sclerostin, OPG, and RANKL were detected by ELISA, and bone turnover markers [CTX, PINP, N-MID-OT and 25(OH)D] were measured by Roche electrochemiluminescence system in two groups. Serum Dkk-1 levels were significantly higher in postmenopausal osteoporosis group than in control group (P<0.001). Univariate analyses revealed that serum Dkk-1 levels were weakly negatively correlated to β-catenin (r=−0.161, P=0.003) and OPG (r=−0.106, P=0.047), while multiple regression analysis showed a negative correlation between serum Dkk-1 levels with β-catenin (β=−0.165, P=0.009) and BMD (β=−0.139, P=0.027), and a positive correlation between serum Dkk-1 levels and CTX (β=0.122, P=0.040) in postmenopausal osteoporosis group. No similar correlations ware observed in control group. The results provided evidence for the role of Dkk-1 in bone metabolism and demonstrated the link of Dkk-1 and Wnt/β-catenin in some ways.

Keywords

dickkopf-related protein 1 / β-catenin / postmenopausal osteoporosis

References

[1] SambrookP, CooperC. Osteoporosis. Lancet, 2006, 367: 2010-2018 PMID: 16782492

[2] GifreL, Ruiz-GaspàS, MonegalA, et al. . Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover. Bone, 2013, 57(1): 272-276 PMID: 23981659

[3] ChamorroMN, SchwartzDR, VonicaA, et al. . FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development. EMBO J, 2005, 24(1): 73-84 PMCID: 544900 PMID: 15592430

[4] Voorzaner-RousselotN, GoehrigD, FaconT, et al. . Platelet is a major contributor to circulating levels of Dickkopf-1: clinical implications in patients with multiple myeloma. Bri J Haematol, 2009, 145(2): 264-266

[5] PinzoneJJ, HallBM, ThudiNK, et al. . The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood, 2009, 113(3): 517-525 PMCID: 2628360 PMID: 18687985

[6] MorvanF, BoulukosK, Clément-LacroixP, et al. . Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Mineral Res, 2006, 21(6): 934-945

[7] LiJ, SarosiI, CattleyRC, et al. . Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone, 2006, 39(4): 754-766 PMID: 16730481

[8] WangFS, KoJY, YehDW, et al. . Modulation of dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss. Endocrinology, 2008, 149(4): 1793-1801 PMID: 18174290

[9] WangFS, KoJY, LinCL, et al. . Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats. Bone, 2007, 40(2): 485-492 PMID: 17055793

[10] TerposE, DimopoulosMA, SezerO. The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma. Leukemia, 2007, 21(9): 1875-1884 PMID: 17611556

[11] KrishnanV, BryantHU, MacdougaldOA. Regulation of bone mass by Wnt signaling. J Clin Inv, 2006, 116(5): 1202-1209

[12] RawadiG, VayssièreB, DunnF, et al. . BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Mineral Res, 2003, 18(10): 1842-1853

[13] SuzukiA, OzonoK, KubotaT, et al. . PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells. J Cell Biochem, 2008, 104(1): 304-317 PMID: 17990294

[14] XuXJ, ShenL, YangYP, et al. . Serum β-catenin levels associated with the ratio of RANKL/OPG in patients with postmenopausal osteoporosis. Int J Endocrinol, 2013, 2013: 534 352

[15] AlbersJ, KellerJ, BaranowskyA, et al. . Canonical Wnt signaling inhibits o-steoclastogenesis independent of osteoprotegerin. J Cell Biol, 2013, 200(4): 537-549 PMCID: 3575535 PMID: 23401003

[16] CleversH, NusseR. Wnt/beta-catenin signaling and disease. Cell, 2012, 149(6): 1192-1205 PMID: 22682243

[17] EssersMA, de Vries-SmitsLM, BarkerN, et al. . Functional interaction between beta-catenin and FOXO in oxdative stress signaling. Science, 2005, 308(5725): 1181-1184 PMID: 15905404

[18] AnastasilakisAD, PolyzosSA, ToulisKA. Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge. Curr Opin Endocrinol Diabetes Obes, 2011, 18(6): 383-388 PMID: 21897222

[19] DrakeMT, SrinivasanB, MödderUI, et al. . Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab, 2010, 95(11): 5056-5062 PMCID: 2968729 PMID: 20631014

[20] XuXJ, ShenL, YangYP, et al. . Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis. Chin Med J, 2013, 126(13): 2480-2484 PMID: 23823821

[21] KyvernitakisI, RachnerTD, UrbschatA, et al. . Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer. J Cancer Res Clin Oncol, 2014, 140(10): 1671-1680 PMID: 24903965

[22] Voorzanger-RousselotN, JourneF, DoriathV, et al. . Assessment of circulating dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases. Calcifi Tissue Int, 2009, 84(5): 348-354

[23] AnastasilakisAD, PolyzosSA, AvramidisA, et al. . The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis. Clin Endocrinol (Oxf), 2010, 72(6): 752-757

[24] BaficoA, LiuGZ, YanivA, et al. . Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol, 2001, 3(7): 683-686 PMID: 11433302

[25] DavidsonG, MaoBY, BarrantesID, et al. . Kremen proteins interact with Dickkopf1 to regulate anteroposterior CNS patterning. Development, 2002, 129(24): 5587-5596 PMID: 12421700

[26] GregoryCA, SinghH, PerryAS, et al. . The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem, 2003, 278(30): 28 067-28 078

[27] ChuEY, HensJ, AndlT, et al. . Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development, 2004, 131(19): 4819-4829 PMID: 15342465

[28] KuhnertF, DavisCR, WangHT, et al. . Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc atl Acad Sci USA, 2004, 101(1): 266-271

[29] VoskaridouE, ChristoulasD, XirakiaC, et al. . Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration. Haematologica, 2009, 94(5): 725-728 PMCID: 2675686 PMID: 19407319

[30] AguileraO, PeñaC, GarcíaJM, et al. . The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihyroxy vitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis, 2007, 28(9): 1877-1884 PMID: 17449905

[31] GlassDA2nd, KarsentyG. Canonical Wnt signalin-in osteoblasts is required for osteoclast differentiation. Ann New York Acad Sci, 2006, 1068: 117-130

[32] DiarraD, StolinaM, PolzerK, et al. . Dickkopf-1 is a master regulator of joint remodeling. Nature Med, 2007, 13(2): 156-163 PMID: 17237793

[33] BellidoT, AliAA, GubrijI, et al. . Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology, 2005, 146(11): 4577-4583 PMID: 16081646

[34] GuoJ, LiuM, YangD, et al. . Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab, 2010, 11(2): 161-171 PMCID: 2819982 PMID: 20142103